OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BCRX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BCRX is expected to report earnings to fall 77.07% to 3 cents per share on October 29

BioCryst Pharmaceuticals BCRX Stock Earnings Reports

Q3'25

Est.

$0.03

Q2'25

Beat

by $0.14

Q1'25

Beat

by $0.07

Q4'24

Missed

by $0.06

Q3'24

Est.

$-0.07

The last earnings report on August 04 showed earnings per share of 15 cents, beating the estimate of 0 cents. With 2.59M shares outstanding, the current market capitalization sits at 1.76B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

BCRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BCRX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BCRX showed earnings on August 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of small molecule pharmaceuticals

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

Biotechnology

Address

4505 Emperor Boulevard

Phone

+1 919 859-1302

Employees

536

Web

https://www.biocryst.com